Huma Qamar - 02 Jan 2025 Form 4 Insider Report for Ocugen, Inc. (OCGN)

Role
Chief Medical Officer
Signature
/s/ Huma Qamar by Shankar Musunuri, her attorney-in-fact
Issuer symbol
OCGN
Transactions as of
02 Jan 2025
Net transactions value
$0
Form type
4
Filing time
06 Jan 2025, 17:01:03 UTC
Previous filing
17 Apr 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OCGN Option (Right to Buy) Award $0 +1,145,468 $0.000000 1,145,468 02 Jan 2025 Common Stock 1,145,468 $0.9000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests annually in equal installments over three years commencing on January 2, 2026, subject to continued service with the Issuer on the applicable vesting dates.